18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
暂无分享,去创建一个
Long Sun | Haojun Chen | Xiu-yi Yu | Y. Pang | Tinghua Meng
[1] X. Lan,et al. Elevated 68Ga-FAPI Accumulation in a Recurrent Angiomyolipoma. , 2020, Clinical nuclear medicine.
[2] Ya-wen Wang,et al. 68Ga-FAPI-04 Accumulation in Myocardial Infarction in a Patient With Neuroendocrine Carcinoma. , 2020, Clinical nuclear medicine.
[3] J. Stone,et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging , 2020, Annals of the Rheumatic Diseases.
[4] Hua Wu,et al. [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Hua Wu,et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[6] J. Dunning,et al. Ground glass opacities management in the lung cancer screening era. , 2018, Annals of translational medicine.
[7] P. V. Van Schil,et al. Management of stage I and II nonsmall cell lung cancer , 2017, European Respiratory Journal.
[8] Quanshi Wang,et al. Adenocarcinoma with BAC Features Presented as the Nonsolid Nodule Is Prone to Be False-Negative on 18F-FDG PET/CT , 2015, BioMed research international.
[9] E. Patz,et al. PET imaging in patients with bronchioloalveolar cell carcinoma. , 2002, Lung cancer.
[10] H. Tonami,et al. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.